Multi-omics and its Applications in Oncology

Reading time: 4 minutes Susan Egbert In the ever-evolving landscape of cancer research, scientists are delving deeper into the complexities of cancer biology. One of the cutting-edge approaches transforming the field is the integration of multi-omics technologies. Multi-omics, the comprehensive analysis of various biological molecules such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics, provides a... Continue Reading →

Unlocking the Secrets of Pancreatic Cancer: How Super Enhancers and RNA-Binding Proteins Illuminate New Paths to Treatment

Reading time: 7 minutes Sakshi Dhavale Did you know that pancreatic cancer has the highest mortality rate among all the major cancers? Because of this, researchers are rigorously working to find a cure for this deadly cancer type. Pancreatic Ductal Adenocarcinoma (PDAC) is the most common type of pancreatic cancer and is highly lethal due... Continue Reading →

Unlocking the Secrets of Pancreatic Cancer: How Super Enhancers and RNA-Binding Proteins Illuminate New Paths to Treatment

Reading time: 7 minutes Sakshi Dhavale Did you know that pancreatic cancer has the highest mortality rate among all the major cancers? Because of this, researchers are rigorously working to find a cure for this deadly cancer type. Pancreatic Ductal Adenocarcinoma (PDAC) is the most common type of pancreatic cancer and is highly lethal due... Continue Reading →

DUBTACs: A new therapeutic approach targeting proteins for cancer treatment

Reading time: 4 minutes Rapon Félicités While the degradation of disease-causing proteins [1] is now possible thanks to targeted protein degradation (TPD) technologies such as PROTACs [2], new targeted protein stabilization (TPS) technologies called DUBTACs [3] have been designed to stabilize and restore proteins that may promote cell proliferation when aberrantly degraded.  Tumor suppressing proteins... Continue Reading →

Spatiotemporal Degradation of a Specific Protein as a New Cancer Therapy

Reading time: 12 minutes Felicites Rapon Recently, chemically engineered molecules have been produced to incite the degradation of a given protein. These molecules are called PROTACs [1], which stands for PROteolysis-TArgeting Chimeras.  How does the degradation of a protein work? The degradation of a protein, also called proteolysis, is achieved by the mechanism of ubiquitination.... Continue Reading →

Extracellular Vesicles in Cancer

Reading time: 5 minutes Charlotte Boyd Extracellular vesicles (EVs) are small bubbles which are released from the cell. Cells produce multiple types of EVs which are different sizes ranging from approximately 30 nanometres to 10,000 nanometres. A nanometre is 10 million times smaller than a centimeter. This means that EVs are tiny and not visible... Continue Reading →

Collagen Can Fuel Cancer Growth

Reading time: 5 minutes Yonika Larasati Accumulating knowledge shows that cancer cells do not thrive in isolation. Just as seeds need suitable soil to flourish into plants, cancer cells might perish without an appropriate environment. This environment, known as the tumor microenvironment (TME), has become an emerging trait of cancer that can be a target... Continue Reading →

Complexities in Metastasis Research

Reading time: 4 minutes Megan Majocha Can you imagine trying to put together clear, acrylic puzzle pieces? It is difficult to put together all the unknowns without a picture. Metastasis research is similar -  trying to put the pieces together without knowing exactly how metastatic cells function in the human body. While cancer metastasis research... Continue Reading →

Anti-Angiogenic Cancer Treatments

Reading time: 5 minutes Aya Elmeligy Angiogenesis is the formation of blood vessels within the body to provide oxygen and nutrients to tissues. Tumors will hijack this process to allow for continued growth and metastasis by forming their own vascular system. Microvessel density within a tumor is often used as a prognosis tool, as the... Continue Reading →

Tumor-on-a-chip: A Better Method for Drug Discovery?

Reading time: 7 minutes Nayela Chowdhury Conventional 2D and 3D models of cancer have widely been utilized in pre-clinical drug development; however, neither of the platforms mimics the dynamic interactions that occur in living tumors. In vivo studies (for example, in small animal models)  have been central in translational cancer research and have contributed largely... Continue Reading →

‘Ubiquitous’ Ubiquitination Pathway and Cancer

Reading time: 4 minutes Deepika Jayaprakash What is common to eukaryotic organisms like animals, plants, fungi, and unicellular organisms? Ubiquitous Ubiquitin!   Ubiquitin (ub) is a small protein found in all eukaryotes that when attached to its target protein can bring about a myriad of cellular processes. The first observed effect of ubiquitination was degradation of... Continue Reading →

Create a website or blog at WordPress.com

Up ↑